Adiponectin Is a Negative Regulator of Bone Mineral and Bone Strength in Growing Mice

Obesity is associated with increased bone mineral density (BMD) but the mechanism for this is unclear. Serum levels of the adipokine adiponectin are inversely correlated with obesity, but results from studies on its relationship to bone mass are conflicting. The objective of this study was to compare bone mineral content (BMC), BMD and biomechanical strength properties of femur and lumbar vertebrae in 8- and 16-week old adiponectin transgenic mice (AdTg). These mice exhibit significantly elevated circulating adiponectin but have similar body weights compared to wild-type (WT) littermates that were used as controls. Female AdTg mice displayed significantly lower femur BMC at 8 and 16 weeks of age and femur neck peak load was significantly lower in 8-week old AdTg mice of both genders compared to controls. The peak load from compression testing of an individual lumbar vertebra was significantly lower in female AdTg mice compared to WT at 8 weeks, and this difference persisted at 16 weeks of age. In addition, lumbar vertebrae BMC was significantly lower in 16-week old male AdTg mice compared to WT although vertebra peak load was not different. Serum adiponectin levels were inversely correlated with femur BMC. In summary, elevated circulating adiponectin inhibits the acquisition of bone mass in growing mice and results in decreased biomechanical measures of functional strength that are surrogate measures of susceptibility to fractures. These results support a role for circulating adiponectin as a metabolic link that can explain, at least in part, the positive relationship between obesity and both bone mass and reduced susceptibility to fractures.

[1]  L. Kuller,et al.  Effects of weight control during the menopausal transition on bone mineral density. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  H. Deng,et al.  Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  J. Jürimäe,et al.  Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. , 2007, American journal of physiology. Endocrinology and metabolism.

[4]  T. Funahashi,et al.  Pathophysiological significance of adiponectin , 2007, Medical Molecular Morphology.

[5]  T. Spector,et al.  Serum adiponectin and bone mineral density in women. , 2007, The Journal of clinical endocrinology and metabolism.

[6]  H. Xie,et al.  Adiponectin Stimulates RANKL and Inhibits OPG Expression in Human Osteoblasts Through the MAPK Signaling Pathway , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  S. Saetung,et al.  Relationship of body composition and circulatory adiponectin to bone mineral density in young premenopausal women. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[8]  Kozo Nakamura,et al.  Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways , 2006, Journal of cellular biochemistry.

[9]  I. Reid,et al.  Nutrition‐Related Peptides and Bone Homeostasis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  D. Balzi,et al.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. , 2005, American journal of physiology. Endocrinology and metabolism.

[11]  H. Xie,et al.  Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.

[12]  P. Trayhurn.  Endocrine and signalling role of adipose tissue: new perspectives on fat. , 2005, Acta physiologica Scandinavica.

[13]  H. Kroger,et al.  Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.

[14]  Tim L Radak,et al.  Caloric restriction and calcium's effect on bone metabolism and body composition in overweight and obese premenopausal women. , 2004, Nutrition reviews.

[15]  S. Shapses,et al.  Overweight Postmenopausal Women Lose Bone With Moderate Weight Reduction and 1 g/day Calcium Intake , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  C. Drevon,et al.  Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.

[17]  W. Ward,et al.  Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. , 2004, Bone.

[18]  U. Dafni,et al.  Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  S. Ishibashi,et al.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. , 2003, Metabolism: clinical and experimental.

[20]  K. Lohman,et al.  Adiponectin as a novel determinant of bone mineral density and visceral fat. , 2003, Bone.

[21]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[22]  M. Stumvoll,et al.  Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. , 2003, Diabetes.

[23]  P. Froguel,et al.  Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.

[24]  T. Douchi,et al.  Difference in the effects of body composition on bone mineral density between pre- and postmenopausal women. , 2002, Maturitas.

[25]  M. Matsuda,et al.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.

[26]  I. Reid.  Relationships among body mass, its components, and bone 1 1 Published simultaneously at BoneKEy-Oste , 2002 .

[27]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[28]  J. Cauley,et al.  Race and Sex Effects on the Association Between Muscle Strength, Soft Tissue, and Bone Mineral Density in Healthy Elders: The Health, Aging, and Body Composition Study , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  T. Douchi,et al.  Effect of Non–Weight‐Bearing Body Fat on Bone Mineral Density Before and After Menopause , 2000, Obstetrics and gynecology.

[30]  W. Applegate,et al.  Effect of Voluntary Weight Loss on Bone Mineral Density in Older Overweight Women , 2000, Journal of the American Geriatrics Society.

[31]  H. Beck-Nielsen,et al.  Correlations between insulin sensitivity and bone mineral density in non‐diabetic men , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[32]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[33]  K. Khaw,et al.  Body composition and bone mass in post‐menopausal women , 1992, Clinical endocrinology.

[34]  H. Xie,et al.  Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[35]  大島 和也.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast , 2007 .

[36]  P. Tonin,et al.  Osteoporosis and body composition. , 2007, Journal of endocrinological investigation.

[37]  田村 朋子.  Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus , 2007 .

[38]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.